Medicare Modernization and Prescription Drug Act of 2002
| Date | Chamber | What was voted on | Result | Yes–No | |
|---|---|---|---|---|---|
| Jun 28, 2002 | House · vote #282 | On Passage | Passed | 221–208 | See who voted → |
| Jun 28, 2002 | House · vote #281 | On Motion to Recommit with Instructions | Failed | 204–223 | See who voted → |
Outlines standard coverage benefit packages for FY 2005. Includes for the standard package an annual deductible of $250, and requires insurers under such package to cover 80 percent of enrollees drug costs from $251 to $1,000, then 50 percent of such costs between $1,001 and the initial coverage limit of $2,000. Requires enrollees to cover all costs between $2,001 and $4,500, and Medicare to cover the entire cost once the beneficiary has reached the $4,500 catastrophic limit. Prescribes a formula for adjustment of the deductible and thresholds for years after 2005.
Establishes a competitive bidding process for negotiating the terms and conditions of PDP sponsors.
Provides for full premium subsidy and reduction of cost-sharing for individuals with incomes below 150 percent of the Federal poverty level. Contains subsidy payments for qualifying entities to promote the participation of PDP sponsors.
Amends SSA title XVIII part C to: (1) provide for the offering of qualified prescription drug coverage under M+C; and (2) create a competitive bidding program for M+C organizations.
Sets out a new Medicare prescription drug discount card endorsement program under Medicare.
Makes a number of other changes with regard to Medicare: (1) part A concerning rural health care, inpatient hospital services, skilled nursing facility services, and hospices; (2) part B concerning physicians services and other services; and (3) part A and B concerning home health services, direct graduate medical education, and other provisions.
Amends SSA title XVIII part E (Miscellaneous) (previously part D) to include a number of regulatory, contracting, and administrative changes.
Establishes the National Bipartisan Commission on the Future of Medicaid.
Amends the Federal Food, Drug, and Cosmetic Act to add requirements for interstate Internet sellers of prescription drugs.
Establishes within the Office of the Director of the National Institutes of Health the Office of Rare Diseases.
Amends the Internal Revenue Code to make specified health-care related tax changes.
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 493.